{"version":"1.0","type":"link","title":"Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer.","author_name":"Wu J 외","author_url":"https://prs-insight.online/author/Wu%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168934","thumbnail_width":1200,"thumbnail_height":630}